Skip to main content
. 2019 Dec 11;20:708. doi: 10.1186/s13063-019-3790-9

Fig. 2.

Fig. 2

Levels of agreement with statements about trial site selection in the Nordic countries # This question applied to only biopharmaceutical respondents (n = 43) ¤ This question applied to only CRO respondents (n = 40). CRO clinical research organization